Hexagon Capital Partners’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-27
Closed -$641 1423
2025
Q1
$641 Hold
27
﹤0.01% 1612
2024
Q4
$572 Buy
27
+25
+1,250% +$656 ﹤0.01% 1670
2024
Q3
$64 Hold
2
﹤0.01% 1554
2024
Q2
$48 Sell
2
-8
-80% -$205 ﹤0.01% 1434
2024
Q1
$298 Sell
10
-111
-92% -$3.47K ﹤0.01% 1375
2023
Q4
$3.87K Sell
121
-14
-10% -$406 ﹤0.01% 1016
2023
Q3
$3.95K Buy
135
+79
+141% +$2.84K ﹤0.01% 948
2023
Q2
$2.52K Sell
56
-21
-27% -$801 ﹤0.01% 1036
2023
Q1
$2.65K Buy
77
+21
+38% +$682 ﹤0.01% 1008
2022
Q4
$1.56K Hold
56
﹤0.01% 1133
2022
Q3
$1K Buy
+56
New +$1.79K ﹤0.01% 1247

Other funds holding SGRY

Hexagon Capital Partners's SGRY Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Surgery Partners (SGRY) in Q2 2025, closing a stake of 27 shares — an estimated $641 sold.

Hexagon Capital Partners first reported a position in SGRY in Q3 2022 and held it in 11 quarters. The position peaked at $3.95K in Q3 2023. 201 funds tracked by Wall St. Rank hold SGRY as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Surgery Partners position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 27 Surgery Partners shares in Q2 2025, an estimated $641.
  • Hexagon Capital Partners first reported a position in Surgery Partners in Q3 2022 and held it in 11 quarters.
  • Hexagon Capital Partners's Surgery Partners position peaked at $3.95K in Q3 2023.
  • 201 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.